Radius Health: Our Next Investment And An Acquisition Candidate

RDUS, LLY

Radius Health (RDUS) is a Waltham, Massachusetts-based emerging biopharmaceutical company. Its flagship product candidate, Abaloparatide has successfully finished phase 3 clinical trials in postmenopausal women with osteoporosis (PDUFA date is on March 30, 2017). Abaloparatide is administered as ...

Radius Health (RDUS) is a Waltham, Massachusetts-based emerging biopharmaceutical company. Its flagship product candidate, Abaloparatide has successfully finished phase 3 clinical trials in postmenopausal women with osteoporosis (PDUFA date is on March 30, 2017). Abaloparatide is administered as ...

This article is only available to subscribers of Vasuda Healthcare Analytics
Learn more about Vasuda Healthcare Analytics